140 related articles for article (PubMed ID: 35411303)
1. Noninvasive Imaging Evaluation Based on Computed Tomography of the Efficacy of Initial Transarterial Chemoembolization to Predict Outcome in Patients with Hepatocellular Carcinoma.
Dai Y; Jiang H; Feng ST; Xia Y; Li J; Zhao S; Wang D; Zeng X; Chen Y; Xin Y; Liu D
J Hepatocell Carcinoma; 2022; 9():273-288. PubMed ID: 35411303
[TBL] [Abstract][Full Text] [Related]
2. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
3. Efficacy and Interpretability Analysis of Noninvasive Imaging Based on Computed Tomography in Patients with Hepatocellular Carcinoma After Initial Transarterial Chemoembolization.
Dai Y; Liu D; Xin Y; Li Y; Wang D; He B; Zeng X; Li J; Jia F; Jiang H
Acad Radiol; 2023 Sep; 30 Suppl 1():S61-S72. PubMed ID: 37393179
[TBL] [Abstract][Full Text] [Related]
4. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma.
Shi ZX; Li CF; Zhao LF; Sun ZQ; Cui LM; Xin YJ; Wang DQ; Kang TR; Jiang HJ
Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):361-369. PubMed ID: 37429785
[TBL] [Abstract][Full Text] [Related]
6. Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma.
Sun Z; Shi Z; Xin Y; Zhao S; Jiang H; Li J; Li J; Jiang H
Acad Radiol; 2023 Sep; 30 Suppl 1():S81-S91. PubMed ID: 36803649
[TBL] [Abstract][Full Text] [Related]
7. Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma.
Zhao Y; Wang N; Wu J; Zhang Q; Lin T; Yao Y; Chen Z; Wang M; Sheng L; Liu J; Song Q; Wang F; An X; Guo Y; Li X; Wu T; Liu AL
Front Oncol; 2021; 11():582788. PubMed ID: 33868988
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging-based radiomics for the prediction of progression-free survival in advanced nasopharyngeal carcinoma.
Li WZ; Wu G; Li TS; Dai GM; Liao YT; Yang QY; Chen F; Huang WY
Front Oncol; 2022; 12():955866. PubMed ID: 36338711
[TBL] [Abstract][Full Text] [Related]
9. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
10. Signature of survival: a
Blanc-Durand P; Van Der Gucht A; Jreige M; Nicod-Lalonde M; Silva-Monteiro M; Prior JO; Denys A; Depeursinge A; Schaefer N
Oncotarget; 2018 Jan; 9(4):4549-4558. PubMed ID: 29435123
[TBL] [Abstract][Full Text] [Related]
11. Radiomics Analysis of Computed Tomography helps predict poor prognostic outcome in COVID-19.
Wu Q; Wang S; Li L; Wu Q; Qian W; Hu Y; Li L; Zhou X; Ma H; Li H; Wang M; Qiu X; Zha Y; Tian J
Theranostics; 2020; 10(16):7231-7244. PubMed ID: 32641989
[No Abstract] [Full Text] [Related]
12. Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Meng XP; Wang YC; Ju S; Lu CQ; Zhong BY; Ni CF; Zhang Q; Yu Q; Xu J; Ji J; Zhang XM; Tang TY; Yang G; Zhao Z
Front Oncol; 2020; 10():1196. PubMed ID: 32850345
[TBL] [Abstract][Full Text] [Related]
13. Radiomic Score as a Potential Imaging Biomarker for Predicting Survival in Patients With Cervical Cancer.
Li H; Zhu M; Jian L; Bi F; Zhang X; Fang C; Wang Y; Wang J; Wu N; Yu X
Front Oncol; 2021; 11():706043. PubMed ID: 34485139
[TBL] [Abstract][Full Text] [Related]
14. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
Kim J; Choi SJ; Lee SH; Lee HY; Park H
AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
[TBL] [Abstract][Full Text] [Related]
15. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization.
Wang ZX; Li J; Wang EX; Xia DD; Bai W; Wang QH; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH
World J Gastroenterol; 2020 Apr; 26(15):1805-1819. PubMed ID: 32351295
[TBL] [Abstract][Full Text] [Related]
16. Radiomics Signature: A potential biomarker for the prediction of survival in Advanced Hepatocellular Carcinoma.
Li L; Kan X; Zhao Y; Liang B; Ye T; Yang L; Zheng C
Int J Med Sci; 2021; 18(11):2276-2284. PubMed ID: 33967603
[No Abstract] [Full Text] [Related]
17. Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study.
Wang ZX; Wang EX; Bai W; Xia DD; Mu W; Li J; Yang QY; Huang M; Xu GH; Sun JH; Li HL; Zhao H; Wu JB; Yang SF; Li JP; Li ZX; Zhang CQ; Zhu XL; Zheng YB; Wang QH; Li J; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH; On Behalf Of China Hcc-Tace Study Group
World J Gastroenterol; 2020 Feb; 26(6):657-669. PubMed ID: 32103874
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma.
Peng J; Lu F; Huang J; Zhang J; Gong W; Hu Y; Wang J
Front Oncol; 2022; 12():853254. PubMed ID: 36324581
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
20. A Novel Multimodal Radiomics Model for Predicting Prognosis of Resected Hepatocellular Carcinoma.
He Y; Hu B; Zhu C; Xu W; Ge Y; Hao X; Dong B; Chen X; Dong Q; Zhou X
Front Oncol; 2022; 12():745258. PubMed ID: 35321432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]